NUTX Insider Trading Activity and SEC Form 4 Filings
NUTX insider trading summary
Over the past 12 months, insiders at Nutex Health Inc. (NUTX) reported 4 open-market purchases worth $147K by 4 insiders and 1 sale worth $43K by 1 insider on SEC Form 4. Net insider buying was $104K.
Latest NUTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Scott J Saunders | Director | Sell | $43K (203 @ $214.25) |
| Mar 20, 2026 | Frank E Jaumot | Director | Buy | $14K (150 @ $93.56) |
| Mar 19, 2026 | Warren Hosseinion | President | Buy | $24K (252 @ $94.07) |
| Mar 13, 2026 | Pamela W. Montgomery | Chief Legal Officer-Healthcare | Buy | $7K (79 @ $88.87) |
| Nov 25, 2025 | Jon Christian Bates | Chief Financial Officer | Buy | $103K (750 @ $136.71) |
| Apr 8, 2025 | Jon Christian Bates | Chief Financial Officer | Buy | $82K (1,000 @ $81.81) |
| Aug 22, 2024 | Jon Christian Bates | Chief Financial Officer | Buy | $29K (1,350 @ $21.46) |
| Aug 20, 2024 | Joshua DeTillio | Chief Operating Officer | Buy | $10K (575 @ $17.40) |
| Aug 19, 2024 | Joshua DeTillio | Chief Operating Officer | Buy | $23K (1,300 @ $17.85) |
| Jun 12, 2024 | Joshua DeTillio | Chief Operating Officer | Buy | $11K (20,000 @ $0.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.